National consensus on acute otitis media;Consenso Nacional sobre otitis media aguda

Acta Otorrinolaringologica Espanola

Volumn 58, Issue 6, 2007, Pages 225-231

  Cervera Escario, J ^a,d   Villafruela, M A ^a   Del Castillo, F ^b   Delgado Rubio, A ^b   De Liria, C Rodrigo G ^b   Picazo, J J ^c  

^a Sociedad Española de Otorrinolaringología Y Patología Cérvico Facial   (Spain)

^b Hospital Clínico   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CEFOTAXIME; CEFPODOXIME PROXETIL; CEFTRIAXONE; CEFUROXIME AXETIL; CEPHALOSPORIN; CLAVULANIC ACID; IBUPROFEN; PARACETAMOL;

ACUTE OTITIS MEDIA; ANTIBIOTIC THERAPY; BRONCHOPNEUMONIA; CONSENSUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARDRUM DISEASE; FACIAL NERVE PARALYSIS; HAEMOPHILUS INFLUENZAE; HUMAN; LABYRINTHITIS; MASTOIDITIS; MORAXELLA CATARRHALIS; MYRINGOTOMY; OTALGIA; OTORHINOLARYNGOLOGY; OTORRHEA; OTOSCOPY; PATHOGENESIS; PENICILLIN ALLERGY; PENICILLIN RESISTANCE; RECURRENT DISEASE; REVIEW; STREPTOCOCCUS PNEUMONIAE; TOMOGRAPHY; TREATMENT FAILURE; TYMPANOSTOMY TUBE; VIRUS INFECTION; VIRUS REPLICATION;

EID: 34547918896     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-6519(07)74918-X     Document Type: Article

References (58)

1. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in Greater Boston: a prospective, cohort study. J Infect Dis. 1989;160:83-94.
2. Rovers MM, Schilder AG, Zielhuis GA, Rosenfeld RM. Otitis media. Lancet. 2004;363:465-73.
3. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J. 1992;11:S7-S11.
4. Del Castillo F, García Perea A, Baquero Artigao F. Bacteriology of acute otitis media in Spain: Aprospective study based on tympanocentesis. Pediatr Infect Dis J. 1996;15:541-3.
5. Ruuskanen O, Arola M, Heikkinen T, Ziegler T. Viruses in acute otitis media: increasing evidence for clinical significance. Pediatr Infect Dis J. 1991;10:425-7.
6. Picazo JJ, Betriu C, Rodríguez-Avial I, Azahares E, Ali Sánchez B. Vigilancia de resistencias a los antimicrobianos: estudio VIRA. Enferm Infecc Microbiol Clin. 2002;20:503-10.
7. García de Lomas J y Grupo Español para Vigilancia de Patógenos Respiratorios. Situación epidemiológica actual y resistencia de los patógenos respiratorios en España. Med Clin (Barc). 1998;110 Supl 1:44-59.
8. Pérez-Trallero E, García de la Fuente C, García-Rey C, Baquero F, Aguilar L, Dal-Ré R, et al. Geographical and ecological análisis of resistance, coresistance, and coupled-resistance to antimicrobials in respiratory pathogenic bacteria in Spain. Antimicrob Agents Chemother. 2005;49:1965-72.
9. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403-9.
10. McEllistrem MC, Adams JM, Patel K, Mendelsohn AB, Kaplan SL, Bradley JS, et al. Acute otitis media due to penicillinnonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2005;40:1738-44.
11. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J. 2004;23:824-8.
12. Dowell SF, Marcy SM, Phillips WR, Gerber MA, Schwartz B. Otitis media. Principles of judicious use of antimicrobial agents. Pediatrics. 1998;101:165-71.
13. Heikkinen T, Ruuskanen O. Signs and syntoms predicting acute otitis media. Arch Pediatr Adolesc Med. 1995;149:26-9.
14. Kontiokari T, Koivunen P, Niemela M, Pokka T, Uhari MT. Symptoms of acute otitis media. Pediatr Infect Dis J. 1998;17: 676-9.
15. Niemela M, Uhari M, Jounio-Ervasti K, Loutonen J, Alho OP, Vierimaa E. Lack of specific symptomatology in children with acute otitis media. Pediatr Infect Dis J. 1994;13:765-8.
16. Del Castillo Martín F. Otitis media aguda: criterios diagnósticos y aproximación terapéutica. An Esp Pediatr. 2002;56 Supl 1:40-7.
17. American Academy of Pediatrics and American Academy of Family Physicians. Diagnosis and management of acute otitis media. Pediatrics. 2004;113:1451-65.
18. Bluestone CD, Gates GA, Klein JO, Lim DJ, Mogi G, Ogra PL, et al. Definitions, terminology, and classification of otitis media. Ann Otol Rhinol Laryngol. 2002;111:8-18.
19. Chan LS, Tanaka S, Shekelle P, Morton SC, Mason W, Marcy SM. Evidence assessment of management of acute otits media: II. Researchgaps and priorities for future research. Pediatrics. 2001;108:148-54.
20. Lim DJ. Recent advances in otitis media: report of the eight reseach conference. Ann Otol Rhinol Laryngol. 2005;114:1-159.
21. Hendley JO. Otitis media. N Engl J Med. 2002;347:1169-74.
22. Giebink GS. Otitis media update: pathogenesis and treatment. Ann Otol Rhinol Laryngol. 1992;101 Suppl 155:21-3.
23. American Academy of Pediatrics. Clinical Practice Guidelines. Otitis media with efussion. Pediatrics. 2004;113:1412-29.
24. Paradise JL, Rockette HE, Colborn DK, Bernard BS, Smith CG, Kurs-Lasky M, et al. Otitis media in 2253 Pittsburg-area infants: prevalence and risks factors during the first two years of life. Pediatrics. 1997;99:318-33.
25. Del Castillo Martín F. Tratamiento de la otitis media aguda en niños. Algunos interrogantes. Enferm Infecc Microbiol Clin. 1997;15:212-6.
26. Leibovitz E, Greenberg D, Piglansky L, Raiz S, Porat N, Press J, et al. Recurrent acute otitis media ocurring within one month from completion of antibiotic therapy: relationship to the original pathogen. Pediatr Infect Dis J. 2003;22:209-15.
27. Gower S, McGuirt WF. Intracranial complications of acute and chronic infectious disease; a problem still with us. Laryngoscope. 1983;93:1028.
28. Luntz M, Keren G, Nusem S, Kronenberg J. Acute mastoiditis-revisited. ENT J. 1994;73:648-54.
29. Kangsanarak J, Fooanant S, Ruckphaopunt K, Navacharoen N, Teotrakul S. Extracranial and intracranial complications of suppurative otitis media. Report of 102 cases. J Laryngol Otol. 1993;107:999-1004.
30. Dudkiewicz M, Livni G, Kornreich L, Nageris B, Ulanovski D, Raveh E. Acute mastoiditis and osteomyelitis of the temporal bone. Int J Pediatr Otorhinolaryngol. 2005;69:1399-405.
31. Ruiz Díaz AI, Del Castillo F, Bilbao Garitagoitia A, Díaz Román C, García Miguel MJ, Borque C. Mastoiditis aguda: una entidad emergente. An Esp Pediatr. 2002;57:427-31.
32. Oestreicher-Kedem Y, Raveh E, Kornreich L, Popovtzer A, Buller N, Nageris B. Complications of mastoiditis in children at the onset of a new millennium. Ann Otol Rhinol Laryngol. 2005;114:147-52.
33. Bluestone CD. Methods of examination: clinical examination. En: Bluestone DC, Stool SE, editors. Pediatric otolaringology. 4th ed. Philadelphia: Saunders; 2003. p. 172-86.
34. Bluestone CD. Role of surgery for otitis media in era of resistant bacteria. Pediatr Infect Dis J. 1998;17:1090-8.
35. Pichichero ME. Assessing the treatment alternatives for acute otitis media. Pediatr Infec Dis J. 1994;13:S27-S34.
36. Klein JO. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J. 1993;12:973-5.
37. Marchant CD, Carlin SA, Johnson CE, Shurin PA. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon". J Pediatr. 1992;120:72-7.
38. Rosenfeld RM, Vertees JE, Carr J, Cipolle RJ, Uden DL, Giebink GS, et al. Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials. J Pediatr. 1994;124:355-67.
39. González de Dios J, Ochoa Sangrador C, Álvarez Calatayud G. Manejo racional de la antibioterapia en las infecciones otorrinolaringológicas en la infancia: revisión crítica de las mejores pruebas científicas. Acta Otorrinolaringol Esp. 2006;57:66-81.
40. Kaleida PH, Casselbrant ML, Rockette ME, Paradise JL, Bluestone CD, Blatter MM, et al. Amoxicillin or myringotomy or both for acute otitis media: result of a randomized clinical trial. Pediatrics. 1991;87:466-74.
41. Harsten G, Prellner K, Heldrup J, Kalm O, Kornfält R. Recurrent acute otitis media. Acta Otolaryngol. 1989;107:111-9.
42. Chan LS, Tanaka GS, Shekelle P, Morton SC, Mason W, Marcy SM. Evidence assessment of management of acute otitis media: II. Research gaps and priorities for future research. Pediatrics. 2001;108:248-54.
43. Carlin SA, Marchant CD, Shuring PA, Johnson CE, Super DM, Rehmus DIM. Host factors and early therapeutic responses in acute otitis media: does symptomatic response correlate with bacterial outcome? J Pediatr. 1991;118:178-83.
44. Dagan R, Leibovitz E, Greenberg D, Yagupsky P, Fliss DM, Leiberman A, et al. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. Pediatr Infect Dis J. 1998;17:776-82.
45. Lister PD, Pong A, Chartrand SA. Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsuspectible pneumococci: support form in vitro pharmacodynamic studies. Antimicrob Agents Chemother. 1997;41: 1026-32.
46. Seikel K, Shelton S, McCracken GH. Middle ear fluid concentrations of amoxicillin after large dosages in children with acute otitis media. Pediatr Infect Dis J. 1997;16:710-1.
47. Dagan R, Hoberman A, Johnson C, Leibovitz EL, Arguedas A, Rose FV, et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J. 2001;20:829-37.
48. Klein JO. Antimicrobial therapy issues facing pediatricians. Pediatr Infect Dis J. 1995;14:415-8.
49. Jacobs MR. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin Microbiol Infect. 2001;7:589-96.
50. Jacobs MR, Bajaksouzian S, Zilles A, Lin G, Pankuck GA, Appelbaum PC. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US Surveillance Study. Antimicrob Agents Chemother. 1999;43:1901-8.
51. Kozyrski AL. Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis. JAMA. 1998;279:1736-42.
52. Leskinen K, Jero J. Complications of acute otitis media in children in southern Finland. Int J Pediatr Otorhinolaryngol. 2004;68:317-24.
53. Spratley J, Silveira H, Álvarez I, Pais-Clemente M. Acute mastoiditis in children: review of the current status. Int J Pediatr Otorhinolaryngol. 2000;56:33-40.
54. Rosenfeld RM. An evidence-based approach to treating otitis media. Pediatr Clin North Am. 1996;43:1165-81.
55. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19:187-95.
56. Clements DA, Langdon L, Bland C, Walter E. Influenza Avaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med. 1995;149:1113-7.
57. Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med. 1998;338:1405-12.
58. Cervera Escario J, Del Castillo Martín F, Gómez Campderá JA, Gras Albert JR, Pérez Piñero B, Villanuela Sanz MA. Indicaciones de la adenoidectomía y amigdalectomía: Documento de Consenso entre la Sociedad Española de Otorrinolaringología y Patología Cervicofacial y la Asociación Española de Pediatría. Acta Otorrinolaringol Esp. 2006;57:59-65.